'Are you PM candidate?' Smriti Irani mocks Rahul Gandhi for Modi debate bid Rishabh Pant suspended: Sourav Ganguly tried blaming Rajasthan Royals, Sanju Samson; this is what BCCI said This Hybrid ...
AstraZeneca, which developed and manufactured the Covid vaccine Covishield. recently admitted that the vaccine could cause TTS (a condition that may cause blood clots and low platelet count) as a ...
“Roughly, the chances of TTS stood at 0.000003 per cent with Covishield in India, whereas globally, the risk stood at 0.0004 per cent," the government official told the news portal on condition ...
As panic spreads over Thrombosis Thrombocytopenia Syndrome, a blood clot side-effect being linked to the vaccine, doctors emphasise that the risk of heart attack and stroke is rare Listen to Story ...
AstraZeneca's COVISHIELD linked to rare TTS side effect, sparking global concern. India rolls out Covaxin alongside Covishield. Bharat Biotech assures Covaxin safety, efficacy, and thorough ...
In India, almost 90% of people who received Covid vaccine, received the AstraZeneca vaccine which in India is called Covishield. Srishty Choudhury Updated : May 01, 2024, 10:57 AM IST Thrombosis ...
Thrombosis Thrombocytopenia Syndrome (TTS)-- a blood clot disorder -- is a rare side effect of AstraZeneca’s Covid vaccine, and the benefits far outweigh the risks of the jab, said doctors here ...
Dr. Raman Gangakhedkar, a leading epidemiologist and former ICMR scientist, stated that only a small fraction, about seven to eight individuals per one million, who receive the Covishield coronavirus ...
Serum Institute of India makes the AZ vaccine in India, and a response is awaited from it on the development. | Photo Credit: RAMAKRISHNA G As AstraZeneca faces a class action suit in the United ...
More than 175 crore doses of Covishield vaccine have been administered to people across India. Now, they are all worried after the vaccine developer AstraZeneca admitted a rare side effect called ...